Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Avyxa Pharma, LLC with status Current. The shortage was first posted on 04/28/2023.
Shortage Details
- Status
- Current
- Company
- Avyxa Pharma, LLC
- Package NDC
- 83831-141-08
- Dosage Form
- Injection
- Presentation
- Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)
- Initial Posting
- 04/28/2023
- Revised Date